Skip to main content
. 2013 Mar 27;28(4):542–549. doi: 10.3346/jkms.2013.28.4.542

Fig. 2.

Fig. 2

Frequencies of aberrant plasma cell immunophenotypes in patients with plasma cell myeloma (PCM). Patients with PCM demonstrated aberrant immunophenotypes in their plasma cells to varying degrees, while all patients with reactive plasmacytosis demonstrated plasma cells with normal immunophenotypes (CD138+, CD19+, CD45+, CD27+, CD56-, and CD20-).